Bought for about 1.25% of the capital.
Pros :
The company's primary production focus is in India, allowing them to benefit from various government schemes such as PLI (Production-Linked Incentive) schemes. This alignment with government initiatives reflects a strategic vision which is beneficial for both the parties.
The presence of a dedicated Research and Development team underscores their commitment to innovation, evident in multiple patents they own. This highlights their focus on futuristic vision.
The company has positioned itself as a premium brand in the market.
Cons :
The valuation is somewhat high, and operating margins have been under pressure in recent quarters. However, this is perceived as a temporary headwind, and confidence exists in the company's ability to overcome this challenge.
Conclusion :
The current price is at a critical inflection point, with the potential for a near-term move of approximately 20%. So I took the position for about 1.25% of the capital.
Acknowledging a downside risk of about 16%, the plan is to consider adding to the position if the price falls to the lower trendline of the Higher Time Frame (HTF) ascending channel.
Any adjustments to the position will be promptly updated. For more insights, follow my profile.